Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Euronext Alternext  >  Theranexus    ALTHX   FR0013286259

THERANEXUS

(ALTHX)
  Report  
Delayed Quote. Delayed Euronext Alternext - 12/06 09:55:44 am
2.4 EUR   -1.23%
10/15THERANEXUS : Theranexus reports cash position as of september 30, 2019
AN
10/15THERANEXUS : 3rd quarter earnings
CO
09/26THERANEXUS : Theranexus announces its first half 2019 results
AN
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Income Statement Evolution
Annual Income Statement Data
Actuals in M € Estimates in M €
Fiscal Period December 2017 2018 2019 (e) 2020 (e) 2021 (e)
Sales 0,16 0,18 0,07 22,1 0,20
EBITDA -2,69 -6,94 -4,92 42,0 -
Operating profit (EBIT) -2,72 -6,99 -6,60 7,10 -9,90
Pre-Tax Profit (EBT) - -7,02 - - -
Net income -2,12 -5,30 -5,80 12,0 -9,90
P/E ratio -27,5x -10,5x -1,73x 0,24x -
EPS ( € ) -0,54 -1,70 -1,39 9,97 -
Dividend per Share (  ) - - - - -
Yield - - - - -
Reference price ( € ) 14,850 17,920 2,400 2,400 2,400
Announcement Date 04/26/2018
04:00pm
04/17/2019
07:30am
- - -
Finances - Leverage
Actuals in M € Estimates in M €
Fiscal Period December 2017 2018 2019 (e) 2020 (e) 2021 (e)
Debt - - - - 2,40
Finance 17,8 11,7 5,10 4,85 -
Operating income (EBITDA) -2,69 -6,94 -4,92 42,0 -
Leverage
(Debt/EBITDA)
- - - - -
Capital Expenditure 0,15 0,33 0,20 0,20 0,30
Free Cash Flow (FCF) -2,04 -5,87 0,57 -1,40 -10,2
Book Value Per Share (BVPS) (  ) - 4,30 - - -
Cash Flow per Share (  ) - -1,78 1,55 0,10 -2,70
Announcement Date 04/26/2018
04:00pm
04/17/2019
07:30am
- - -
Balance Sheet Analysis
Assessed data source
© 2019 S&P Global Market Intelligence
Financial Ratios

Size 2019e 2020e
Capitalization 9 M € -
Entreprise Value (EV) 3,59 M € 3,84 M €
Valuation 2019e 2020e
P/E ratio (Price / EPS) -1,73x 0,24x
Capitalization / Revenue 130x 0,39x
EV / Revenue 53,9x 0,16x
EV / EBITDA -0,73x 0,09x
Yield (DPS / Price) - -
Price to book (Price / BVPS) - -
Profitability 2019e 2020e
Operating Margin (EBIT / Sales) -9 900% 32,2%
Operating Leverage (Delta EBIT / Delta Sales) - 0,01x
Net Margin (Net Profit / Revenue) -8 700% 54,4%
ROA (Net Profit / Asset) - -
ROE (Net Profit / Equities) -0,36% 0,79%
Rate of Dividend - -
Balance Sheet Analysis 2019e 2020e
CAPEX / Sales   300% 0,91%
Cash Flow / Sales 8 395% 1,64%
Capital Intensity (Assets / Sales) - -
Financial Leverage (Net Debt / EBITDA) - -
EPS & Dividend